In individuals with pancreatic tumors, a high expression of macrophage migration inhibitory factor (MIF) was detected from PDAC-derived EVs, particularly in patients who subsequently developed liver metastasis, suggesting MIF as a potential prognostic indicator for the development of PDAC liver metastasis. Here, MIF is linked to pancreatic neoplasm.